CSIMarket
 
Amedisys Inc   (AMED)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 
Price: $93.2100 $0.43 0.463%
Day's High: $93.39 Week Perf: -0.11 %
Day's Low: $ 92.47 30 Day Perf: 0.01 %
Volume (M): 442 52 Wk High: $ 96.44
Volume (M$): $ 41,208 52 Wk Avg: $89.62
Open: $92.47 52 Wk Low: $69.37



 Market Capitalization (Millions $) 3,028
 Shares Outstanding (Millions) 32
 Employees 22,000
 Revenues (TTM) (Millions $) 2,236
 Net Income (TTM) (Millions $) -11
 Cash Flow (TTM) (Millions $) 85
 Capital Exp. (TTM) (Millions $) 13

Amedisys Inc
Introduction:
Amedisys Inc. is a leading healthcare company that provides comprehensive home health services, hospice programs, personal care services, and care coordination services. Amedisys aims to improve patient outcomes and provide high-quality care services to patients in their homes. The company has a nationwide reach and provides a wide range of medical services to patients ranging from infants to elderly patients.

History:
Amedisys was incorporated in 1982, and it started its operations as a single-location hospice provider in Baton Rouge, Louisiana. The company's primary focus was on providing hospice services for terminally ill patients. Over the years, the company expanded its services and established home health services and personal care services. Today, the company has grown into a massive network of healthcare providers, serving patients across the United States.

Services:
Amedisys provides various services to ensure that patients receive the highest quality of home-based care. The company's home health services include skilled nursing, physical therapy, occupational therapy, speech therapy, medical social services, and other services aimed at helping patients recover from illnesses or injuries at home. The company's hospice services offer a comprehensive approach to end-of-life care, providing comfort and support to terminally ill patients and their families. Personal care services offered by Amedisys include non-medical assistance with daily living activities such as meal preparation, transportation, and companionship.

Operations:
Amedisys operates in 38 states in the United States, serving patients who need help to recover from illness or injury in their homes. The company has over 21,000 employees and a team of more than 4,000 clinicians, including registered nurses, physical therapists, occupational therapists, and social workers. Amedisys has a network of more than 330 care centers and offices throughout the United States, making it one of the most extensive home health care providers in the country.

Growth:
Over the years, Amedisys has grown exponentially, expanding its services and its geographic reach. The company has focused on mergers and acquisitions to achieve its growth objectives. The company has strategically acquired other home health providers and hospice providers to expand its footprint in the United States. For instance, in 2019, the company acquired Compassionate Care Hospice, a leading provider of hospice services, to expand its hospice services to more patients across the country.

Conclusion:
Amedisys is a leading healthcare provider that aims to provide high-quality care services to patients in their homes. The company's goal is to improve patient outcomes by providing personalized care, enhancing patient comfort, and improving overall quality of life. Amedisys provides various medical services, including home health services, hospice care, and personal care services, and operates in 38 states, serving patients across the United States. The company has grown into a massive healthcare network, and has expanded its services and operations through strategic acquisitions to meet the increasing demand for home health care services.


   Company Address: 3854 American Way, Suite A, Baton Rouge, 70816 LA
   Company Phone Number: 292-2031   Stock Exchange / Ticker: NASDAQ AMED
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Amedisys Inc

Amedisys Inc. Leads the Way in Healthcare Innovation with New Molecular Testing Partnership

The stock market can be a volatile and unpredictable place, with investors constantly seeking out opportunities for growth and stability. However, amidst the ups and downs, there are moments when companies stand out for their innovative approaches and potential for success. Amedisys, Inc., a leading provider of home health, hospice, and high-acuity care, has recently made a groundbreaking move that could have a significant impact on its future prospects.
Amedisys has partnered with Patient Choice Laboratories to offer advanced molecular testing across its care centers nationwide. This collaboration intends to revolutionize infection diagnosis by utilizing cutting-edge technology to swiftly and accurately identify pathogens in urine, respiratory, and wound infections. This move marks a significant step forward in the healthcare industry and showcases Amedisys' commitment to providing high-quality care to its patients.

Partnership

Amedisys Boosts Infection Diagnosis with Advanced Molecular Testing

Published Thu, Feb 8 2024 12:30 PM UTC

In a groundbreaking move, Amedisys, Inc., a leading provider of home health, hospice, and high-acuity care, has joined forces with Patient Choice Laboratories to offer advanced molecular testing across its care centers nationwide. This collaboration aims to revolutionize infection diagnosis by utilizing cutting-edge technology to swiftly and accurately identify pathogens in ...

Amedisys Inc

Amedisys Inc Defies Revenue Slide: Earnings per Share Hold Strong in Q3 2023

Amedisys Inc, a leading healthcare facilities company, recently announced its financial results for the July to September 2023 interval. Despite a modest revenue contraction, the company's earnings per share remained unchanged at $0.79. Amedisys reported a year-on-year revenue decrease of -0.314%, with revenue totaling $556.24 million.
In comparison to the previous quarter, Amedisys showcased positive growth as income per share improved from $-2.46 per share. Additionally, revenue experienced a 0.591% increase from $552.97 million. These positive figures demonstrate the company's ability to adapt and perform well in the challenging healthcare industry.

Amedisys Inc

Amedisys Inc. Falls Short in Q2 2023: Reveals Decrease in Earnings and Revenue Amid Challenging Fiscal Period

/>The stock market is a volatile place where companies constantly face ups and downs. In the case of Amedisys Inc., a leading healthcare facilities provider, the second quarter of 2023 earnings season brought disappointing results. Amedisys Inc. reported a significant shortfall in earnings and a decline in revenue compared to the same period last year. This article will delve into the details of their financial struggles and highlight the interesting facts surrounding this decline.
Earnings Shortfall and Reduced EPS:
Amedisys Inc. experienced a significant drop in earnings in the second quarter of 2023, with a loss of $2.46 per share compared to a gain of $0.91 per share during the same period in the previous year. Additionally, the company's EPS fell from $0.77 per share in the prior reporting season, indicating a downward trend. These disappointing figures highlight the challenges Amedisys Inc. faces in maintaining profitability and delivering returns to its shareholders.

Amedisys Inc

Amedisys Inc Surprises Wall Street with Modest Revenue Growth in Q1 2023

Amedisys Inc, a leading healthcare company in the United States, has recently released its first quarter 2023 earnings report, which shows mixed results in terms of revenue and earnings. The report highlights a revenue increase of 2.042%, but still indicates a decrease of -20.62% in income compared to the same reporting period in the previous year.
The company's revenue for the first quarter of 2023 was reported to be $556.39 million while earnings per share (EPS) were recorded at $0.77. These figures reflect a decline of -1.01% in revenue and -21.08% in EPS compared to the previous reporting period. The company's earnings for the first quarter also suffered a decline of -21.45% from $31.713 million to $24.909 million in the same period a year before.






 

Amedisys Inc's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Amedisys Inc does not provide revenue guidance.

Earnings Outlook
Amedisys Inc does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com